Related Experiment Video
Updated: Jul 16, 2026
05:08
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Chemokines in gastrointestinal disorders.
K Gijsbers1, K Geboes, J Van Damme
1Laboratory of Molecular Immunology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium.
Current Drug Targets
|February 4, 2006
Summary
Chemokines are crucial for immune cell movement in the gut, impacting inflammatory bowel diseases and gastrointestinal tumors. Their role in inflammation and cancer offers potential therapeutic strategies.
Area of Science:
- Gastroenterology and Immunology
- Molecular Biology
Background:
- The intestine requires robust immune responses to antigens and pathogens.
- Chemokines regulate immune cell trafficking, hematopoiesis, angiogenesis, and tumor metastasis.
Purpose of the Study:
- To review the role of chemokines in gastrointestinal disorders, specifically inflammatory bowel diseases (IBD) and gastrointestinal tumors.
- To explore the therapeutic potential of chemokines in IBD and cancer treatment.
Main Methods:
- Literature review focusing on chemokine expression and function in the gastrointestinal tract.
- Analysis of studies investigating chemokine involvement in the pathogenesis of IBD and gastrointestinal cancers.
Main Results:
- Chemokine expression in IBD correlates with disease activity, mediating aberrant leukocyte recruitment and intestinal damage.
- Chemokines exhibit dual roles in cancer: therapeutic potential via angiostasis and anti-tumor immunity, but also promotion of metastasis.
Conclusions:
- Chemokines are key players in the immune dysregulation of IBD and the progression of gastrointestinal tumors.
- Targeting chemokines offers promising therapeutic avenues for gastrointestinal diseases, though potential pro-metastatic effects must be considered.
More Related Videos
Related Concept Videos
01:20Gastrointestinal Motility Disorders
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:30Other Disorders of Digestive System
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...